JOHN MARSH: Open Payments
NPI 1699064659 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 18 payments from 8 companies in 2025. Trend: 2023 $363 · 2024 $255 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $397 |
| Collegium Pharmaceutical, Inc. | 3 | $72 |
| Medtronic, Inc. | 2 | $41 |
| SI-BONE, INC. | 1 | $32 |
| Boston Scientific Corporation | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Valinor Pharma, LLC | 1 | $16 |
Products named: ETERNA, Belbuca, PROCLAIM, INCEPTIV, General - Therapies, AXIUM, JOURNAVX, RELISTOR.
Industry payments across MS — which companies pay providers there.
